bcl-2-Associated X Protein
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"bcl-2-Associated X Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A member of the Bcl-2 protein family and homologous partner of C-BCL-2 PROTO-ONCOGENE PROTEIN. It regulates the release of CYTOCHROME C and APOPTOSIS INDUCING FACTOR from the MITOCHONDRIA. Several isoforms of BCL2-associated X protein occur due to ALTERNATIVE SPLICING of the mRNA for this protein.
    
			
			
				
				
					
						| Descriptor ID | D051028 | 
					
						| MeSH Number(s) | D12.644.360.075.718.400 D12.776.476.075.718.400 | 
					
						| Concept/Terms | bcl-2-Associated X Proteinbcl-2-Associated X ProteinProtein, bcl-2-Associated XX Protein, bcl-2-Associatedbcl 2 Associated X ProteinBax Apoptosis Regulator ProteinBax Proteinbcl2-Associated X Proteinbcl2 Associated X Protein
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "bcl-2-Associated X Protein".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "bcl-2-Associated X Protein".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "bcl-2-Associated X Protein" by people in this website by year, and whether "bcl-2-Associated X Protein" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1999 | 0 | 1 | 1 | 
| 2001 | 0 | 1 | 1 | 
| 2006 | 1 | 0 | 1 | 
| 2008 | 0 | 1 | 1 | 
| 2009 | 1 | 0 | 1 | 
| 2011 | 0 | 1 | 1 | 
| 2018 | 0 | 1 | 1 | 
| 2023 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "bcl-2-Associated X Protein" by people in Profiles.
						
					
								- 
								Unconventional Source of Neurotoxic Protein Aggregation from Organelle Off-Target Bax?2 in Alzheimer's Disease. Biomolecules. 2023 06 10; 13(6). 
- 
								Sevoflurane Protects Hepatocytes From Ischemic Injury by Reducing Reactive Oxygen Species Signaling of Hepatic Stellate Cells: Translational Findings Based on a Clinical Trial. Anesth Analg. 2018 10; 127(4):1058-1065. 
- 
								Pseudomonas aeruginosa ExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity. J Biol Chem. 2015 Nov 27; 290(48):29063-73. 
- 
								Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One. 2011; 6(8):e23354. 
- 
								Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells. Environ Mol Mutagen. 2009 Apr; 50(3):201-12. 
- 
								Rap1b GTPase ameliorates glucose-induced mitochondrial dysfunction. J Am Soc Nephrol. 2008 Dec; 19(12):2293-301. 
- 
								Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin Cancer Res. 2006 Nov 15; 12(22):6836-43. 
- 
								Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 2001 Sep; 15(11):2007-9. 
- 
								Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J. 1999 Feb 01; 18(3):632-43.